VIEMED HEALTHCARE, INC. (VMD) Operating Margin
- Operating margin · 12 months: Value 7.55%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 7.55% | Operating income / revenue. Period ending 2026-06-30. $22.77M ÷ $301.61M × 100 ≈ 7.55% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 22.77M USD | Operating Income (Loss) |
| Revenue | 301.61M USD | |
| Cost of products and services | 128.28M USD | Cost of Goods and Services Sold |
| Research and development | 2.46M USD | Research and Development Expense |
| Selling, general and administration | 136.06M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22.77M | $301.61M | $128.28M | $2.46M | $136.06M | 7.55% |
| 2026-03-31 | $23.40M | $286.56M | $121.56M | $2.80M | $127.73M | 8.17% |
| 2025-12-31 | $22.95M | $270.28M | $114.82M | $3.02M | $121.37M | 8.49% |
| 2025-09-30 | $21.03M | $254.79M | $107.30M | $3.22M | $117.36M | 8.25% |
| 2025-06-30 | $21.02M | $240.88M | $100.36M | $3.20M | $112.11M | 8.72% |
| 2025-03-31 | $19.54M | $232.79M | $96.11M | $3.12M | $109.81M | 8.39% |
| 2024-12-31 | $17.90M | $224.26M | $91.05M | $3.07M | $106.20M | 7.98% |
| 2024-09-30 | $16.74M | $214.30M | $85.13M | $2.92M | $101.89M | 7.81% |
| 2024-06-30 | $15.31M | $205.70M | $80.33M | $2.75M | $98.88M | 7.45% |
| 2024-03-31 | $14.60M | $194.04M | $75.46M | $2.75M | $92.94M | 7.52% |
| 2023-12-31 | $14.33M | $183.01M | $70.22M | $2.78M | $87.88M | 7.83% |
| 2023-09-30 | $12.57M | $169.78M | $66.21M | $2.85M | $81.15M | 7.41% |
| 2023-06-30 | $9.84M | $156.13M | $61.48M | $2.93M | $75.17M | 6.30% |
| 2023-03-31 | $7.94M | $146.13M | $57.19M | $2.84M | $72.15M | 5.43% |
| 2022-12-31 | $8.25M | $138.83M | $54.15M | $2.70M | $68.16M | 5.94% |
| 2022-09-30 | $9.38M | $133.29M | $51.84M | $2.59M | $65.23M | 7.04% |
| 2022-06-30 | $10.83M | $126.81M | $48.64M | $2.49M | $60.81M | 8.54% |
| 2022-03-31 | $12.50M | $120.90M | $45.49M | $2.40M | $56.16M | 10.34% |
| 2021-12-31 | $11.58M | $117.06M | $43.65M | $2.11M | $54.89M | 9.89% |
| 2021-09-30 | $12.18M | $116.30M | $43.38M | $1.89M | $52.93M | 10.47% |
| 2021-06-30 | $13.30M | $120.46M | $46.47M | $1.56M | $53.22M | 11.04% |
| 2021-03-31 | $23.50M | $135.92M | $53.62M | $1.25M | $56.76M | 17.29% |
| 2020-12-31 | $26.78M | $131.31M | $51.20M | $1.08M | $52.83M | 20.40% |
| 2020-09-30 | $24.09M | $121.56M | $46.38M | $891.00K | $50.73M | 19.82% |
| 2020-06-30 | $22.24M | $108.48M | $38.70M | $856.00K | $47.41M | 20.50% |
| 2020-03-31 | $11.05M | $85.95M | $27.46M | $788.00K | $42.50M | 12.85% |
| 2019-12-31 | $8.75M | $80.26M | $24.25M | $848.00K | $41.38M | 10.90% |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $10.01M | $68.62M | $18.17M | $234.00K | $36.51M | 14.58% |
| 2018-12-31 | $10.06M | $64.46M | $16.69M | $0.00 | $34.30M | 15.60% |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |